Arch Biopartners Inc. (TSXV: ARCH)
Canada
· Delayed Price · Currency is CAD 1.890
+0.040 (2.16%)
Nov 21, 2024, 9:45 AM EST
Arch Biopartners Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
| Revenue | 1.38 | 1.98 | 0.96 | 3.89 | 0.07 | 0.09 | Upgrade
|
| Revenue Growth (YoY) | -44.41% | 105.63% | -75.18% | 5625.22% | -27.69% | - | Upgrade
|
| Cost of Revenue | 1.56 | 2.11 | 1.47 | 4.04 | 2.19 | 1.5 | Upgrade
|
| Gross Profit | -0.17 | -0.13 | -0.5 | -0.15 | -2.12 | -1.4 | Upgrade
|
| Selling, General & Admin | 0.91 | 0.81 | 0.47 | 0.56 | 0.53 | 0.43 | Upgrade
|
| Operating Expenses | 1.75 | 2.77 | 0.49 | 0.67 | 2.26 | 0.51 | Upgrade
|
| Operating Income | -1.92 | -2.9 | -1 | -0.82 | -4.38 | -1.91 | Upgrade
|
| Interest Expense | -0.39 | -0.36 | -0.31 | -0.27 | -0.18 | -0.11 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.02 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.19 | 0.01 | -0.02 | -0 | 0.01 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.09 | -0.1 | -0.08 | -0.07 | -0.08 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | -2.57 | -3.33 | -1.41 | -1.17 | -4.63 | -2.09 | Upgrade
|
| Pretax Income | -2.57 | -3.33 | -1.41 | -1.17 | -4.63 | -2.09 | Upgrade
|
| Net Income | -2.57 | -3.33 | -1.41 | -1.17 | -4.63 | -2.09 | Upgrade
|
| Net Income to Common | -2.57 | -3.33 | -1.41 | -1.17 | -4.63 | -2.09 | Upgrade
|
| Shares Outstanding (Basic) | 64 | 62 | 62 | 61 | 60 | 59 | Upgrade
|
| Shares Outstanding (Diluted) | 64 | 62 | 62 | 61 | 60 | 59 | Upgrade
|
| Shares Change (YoY) | 2.27% | 0.49% | 1.36% | 2.34% | 2.18% | 2.84% | Upgrade
|
| EPS (Basic) | -0.04 | -0.05 | -0.02 | -0.02 | -0.08 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.05 | -0.02 | -0.02 | -0.08 | -0.04 | Upgrade
|
| Free Cash Flow | -2.72 | -0.23 | 0.48 | -2.98 | -1.9 | -1.8 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.00 | 0.01 | -0.05 | -0.03 | -0.03 | Upgrade
|
| Gross Margin | -12.53% | -6.50% | -52.13% | -3.85% | - | - | Upgrade
|
| Operating Margin | -138.76% | -145.99% | -103.36% | -21.08% | -6450.03% | -2038.85% | Upgrade
|
| Profit Margin | -185.89% | -167.71% | -145.94% | -30.10% | -6818.28% | -2229.16% | Upgrade
|
| Free Cash Flow Margin | -196.35% | -11.80% | 49.70% | -76.69% | -2805.86% | -1922.31% | Upgrade
|
| EBIT | -1.92 | -2.9 | -1 | -0.82 | -4.38 | -1.91 | Upgrade
|
| EBIT Margin | -138.76% | -145.99% | -103.36% | -21.08% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.